Modalis Therapeutics Corporation (TYO:4883)
Japan
· Delayed Price · Currency is JPY 75.00
-1.00 (-1.32%)
May 2, 2025, 3:30 PM JST
Modalis Therapeutics Market Cap
Modalis Therapeutics has a market cap or net worth of 5.52 billion as of May 5, 2025. Its market cap has increased by 77.33% in one year.
Market Cap
5.52B
Enterprise Value
1.94B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
75.00
Market Cap Chart
Since August 3, 2020, Modalis Therapeutics's market cap has decreased from 60.66B to 5.52B, a decrease of -90.91%. That is a compound annual growth rate of -39.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 5.52B | -22.08% |
| Dec 30, 2024 | 7.08B | 80.79% |
| Dec 29, 2023 | 3.92B | -59.92% |
| Dec 30, 2022 | 9.77B | -44.97% |
| Dec 30, 2021 | 17.75B | -71.83% |
| Dec 30, 2020 | 63.03B | 3.92% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 14.19T |
| Daiichi Sankyo Company | 6,895.29B |
| Takeda Pharmaceutical Company | 6,679.44B |
| HOYA Corporation | 6,188.25B |
| Terumo | 4,175.50B |
| Otsuka Holdings | 4,076.15B |
| Astellas Pharma | 2,609.98B |
| Olympus | 2,211.54B |